Chevy Chase Trust Holdings LLC acquired a new position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 40,378 shares of the biotechnology company’s stock, valued at approximately $7,879,000. Chevy Chase Trust Holdings LLC owned about 0.05% of Axon Enterprise as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in AXON. Kovack Advisors Inc. raised its stake in Axon Enterprise by 1.2% during the 1st quarter. Kovack Advisors Inc. now owns 3,997 shares of the biotechnology company’s stock valued at $899,000 after buying an additional 47 shares during the last quarter. AE Wealth Management LLC grew its position in shares of Axon Enterprise by 3.9% during the 1st quarter. AE Wealth Management LLC now owns 1,418 shares of the biotechnology company’s stock valued at $319,000 after acquiring an additional 53 shares during the period. Mercer Global Advisors Inc. ADV grew its position in shares of Axon Enterprise by 2.4% during the 1st quarter. Mercer Global Advisors Inc. ADV now owns 2,499 shares of the biotechnology company’s stock valued at $562,000 after acquiring an additional 59 shares during the period. Oak Ridge Investments LLC grew its position in shares of Axon Enterprise by 0.6% during the 1st quarter. Oak Ridge Investments LLC now owns 10,484 shares of the biotechnology company’s stock valued at $2,357,000 after acquiring an additional 61 shares during the period. Finally, O Shaughnessy Asset Management LLC grew its position in shares of Axon Enterprise by 5.4% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 1,288 shares of the biotechnology company’s stock valued at $290,000 after acquiring an additional 66 shares during the period. 76.52% of the stock is currently owned by hedge funds and other institutional investors.
Axon Enterprise Stock Up 3.1 %
AXON opened at $215.29 on Wednesday. The firm has a 50-day simple moving average of $201.14 and a two-hundred day simple moving average of $200.95. Axon Enterprise, Inc. has a 52 week low of $115.03 and a 52 week high of $229.95. The company has a market capitalization of $16.10 billion, a PE ratio of 160.67 and a beta of 0.88. The company has a quick ratio of 2.98, a current ratio of 3.38 and a debt-to-equity ratio of 0.47.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings data on Tuesday, August 8th. The biotechnology company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.33 by $0.47. Axon Enterprise had a net margin of 7.24% and a return on equity of 10.88%. The business had revenue of $374.61 million during the quarter, compared to the consensus estimate of $347.53 million. Analysts forecast that Axon Enterprise, Inc. will post 1.96 earnings per share for the current fiscal year.
Insider Buying and Selling at Axon Enterprise
In other news, President Joshua Isner sold 29,699 shares of the company’s stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of $196.37, for a total transaction of $5,831,992.63. Following the sale, the president now directly owns 356,489 shares in the company, valued at approximately $70,003,744.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Julie A. Cullivan sold 515 shares of the stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $214.47, for a total value of $110,452.05. Following the sale, the director now directly owns 5,367 shares of the company’s stock, valued at approximately $1,151,060.49. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Joshua Isner sold 29,699 shares of the stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of $196.37, for a total transaction of $5,831,992.63. Following the completion of the sale, the president now directly owns 356,489 shares in the company, valued at $70,003,744.93. The disclosure for this sale can be found here. Insiders own 6.10% of the company’s stock.
Analyst Ratings Changes
AXON has been the subject of a number of recent research reports. Barclays cut their price objective on shares of Axon Enterprise from $256.00 to $239.00 and set an “overweight” rating for the company in a research report on Wednesday, August 9th. StockNews.com initiated coverage on shares of Axon Enterprise in a research report on Thursday, October 5th. They set a “hold” rating for the company. JMP Securities reissued a “market outperform” rating and set a $235.00 price objective on shares of Axon Enterprise in a research report on Friday, September 29th. Needham & Company LLC reaffirmed a “buy” rating and issued a $240.00 target price on shares of Axon Enterprise in a report on Wednesday, August 9th. Finally, Morgan Stanley started coverage on shares of Axon Enterprise in a report on Tuesday, August 22nd. They issued an “equal weight” rating and a $230.00 target price for the company. Two analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $244.73.
Get Our Latest Research Report on AXON
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axon Enterprise, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Axon Enterprise wasn’t on the list.
While Axon Enterprise currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
